{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:37:25Z","timestamp":1789227445220,"version":"build-2803163510"},"reference-count":27,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2024,4,1]]},"DOI":"10.5551\/jat.64183","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T22:47:26Z","timestamp":1696286846000},"page":"355-367","source":"Crossref","is-referenced-by-count":12,"title":["Prognostic Significance of Soluble PD-L1 on Cardiovascular Outcomes in Patients with Coronary Artery Disease"],"prefix":"10.5551","volume":"31","author":[{"given":"Shuhei","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Fujisue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshi","family":"Yamanaga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sueta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Usuku","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hoshiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Kanazawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Arima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Division of Advanced Cardiovascular Therapeutics, Department of Cardiovascular Medicine, Kumamoto University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Liu Y, Jia SD, Yao Y, Tang XF, Xu N, Jiang L, Gao Z, Chen J, Yang YJ, Gao RL, Xu B and Yuan JQ: Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. J Cardiol, 2020; 75: 60-65","DOI":"10.1016\/j.jjcc.2019.06.012"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Moriya J: Critical roles of inflammation in atherosclerosis. J Cardiol, 2019; 73: 22-27","DOI":"10.1016\/j.jjcc.2018.05.010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Fujisue K, Sugamura K, Kurokawa H, Matsubara J, Ishii M, Izumiya Y, Kaikita K and Sugiyama S: Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction. Circ J, 2017; 81: 1174-1182","DOI":"10.1253\/circj.CJ-16-0949"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Grivel JC, Ivanova O, Pinegina N, Blank PS, Shpektor A, Margolis LB and Vasilieva E: Activation of T lymphocytes in atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 2011; 31: 2929-2937","DOI":"10.1161\/ATVBAHA.111.237081"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Foks AC and Kuiper J: Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis. Br J Pharmacol, 2017; 174: 3940-3955","DOI":"10.1111\/bph.13802"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Dopheide JF, Sester U, Schlitt A, Horstick G, Rupprecht HJ, Munzel T and Blankenberg S: Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro. Coron Artery Dis, 2007; 18: 523-531","DOI":"10.1097\/MCA.0b013e3282eff1ad"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Leseche G, Devue C, Duriez M, Brandes RP, Lutgens E, Tedgui A and Boulanger CM: CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol, 2008; 52: 1302-1311","DOI":"10.1016\/j.jacc.2008.07.032"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Winkels H, Meiler S, Smeets E, Lievens D, Engel D, Spitz C, Burger C, Rinne P, Beckers L, Dandl A, Reim S, Ahmadsei M, Van den Bossche J, Holdt LM, Megens RT, Schmitt M, de Winther M, Biessen EA, Borst J, Faussner A, Weber C, Lutgens E and Gerdes N: CD70 limits atherosclerosis and promotes macrophage function. Thromb Haemost, 2017; 117: 164-175","DOI":"10.1160\/TH16-04-0318"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bu DX, Tarrio M, Maganto-Garcia E, Stavrakis G, Tajima G, Lederer J, Jarolim P, Freeman GJ, Sharpe AH and Lichtman AH: Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arterioscler Thromb Vasc Biol, 2011; 31: 1100-1107","DOI":"10.1161\/ATVBAHA.111.224709"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Lee J, Zhuang Y, Wei X, Shang F, Wang J, Zhang Y, Liu X, Yang Y, Liu L and Zheng Q: Contributions of PD-1\/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis. J Mol Cell Cardiol, 2009; 46: 169-176","DOI":"10.1016\/j.yjmcc.2008.10.028"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tomita Y, Sueta D, Kakiuchi Y, Saeki S, Saruwatari K, Sakata S, Jodai T, Migiyama Y, Akaike K, Hirosako S, Fujisue K, Yamamura S, Miyazaki S, Takashio S, Izumiya Y, Nakamura K, Tsujita K, Ichiyasu H and Fujii K: Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody. Ann Oncol, 2017; 28: 2893-2895","DOI":"10.1093\/annonc\/mdx326"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Fujisue K, Yamamoto E, Sueta D, Takae M, Nishihara T, Komorita T, Usuku H, Yamanaga K, Ito M, Hoshiyama T, Kanazawa H, Takashio S, Arima Y, Araki S, Soejima H, Kaikita K, Matsushita K and Tsujita K: Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome. Int J Cardiol, 2022; 349: 1-6","DOI":"10.1016\/j.ijcard.2021.11.060"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA and White HD: Fourth Universal Definition of Myocardial Infarction (2018). Circulation, 2018; 138: e618-e651","DOI":"10.1161\/CIR.0000000000000617"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H and Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97: 1837-1847","DOI":"10.1161\/01.CIR.97.18.1837"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wang J, Zhao Y, Tang LL, Mueller C and Li Q: A resample-replace lasso procedure for combining high-dimensional markers with limit of detection. J Appl Stat, 2022; 49: 4278-4293","DOI":"10.1080\/02664763.2021.1977785"},{"key":"16","unstructured":"16) Ogden TL: Handling results below the level of detection. Ann Occup Hyg, 2010; 54: 255-256"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GB, Ng D, Pearson GJ, Sniderman A, Stone JA and Ur E: 2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol, 2009; 25: 567-579","DOI":"10.1016\/S0828-282X(09)70715-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Anderson TJ, Gr\u00e9goire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J, Jr., Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA and Ur E: 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol, 2013; 29: 151-167","DOI":"10.1016\/j.cjca.2012.11.032"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shi B, Du X, Wang Q, Chen Y and Zhang X: Increased PD-1 on CD4(+)CD28(-) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases. Metabolism, 2013; 62: 778-785","DOI":"10.1016\/j.metabol.2012.12.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Du Y, Nie L, Xu L, Wu X, Zhang S and Xue J: Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity. Scand J Immunol, 2020; 92: e12884","DOI":"10.1111\/sji.12884"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Banerjee D, Monaghan S, Zhao R, Walsh T, Palmisciano A, Phillips GS, Opal S and Levy MM: Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis. Crit Care, 2018; 22: 146","DOI":"10.1186\/s13054-018-2064-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Chen Y, Wang Q, Shi B, Xu P, Hu Z, Bai L and Zhang X: Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines. Cytokine, 2011; 56: 231-238","DOI":"10.1016\/j.cyto.2011.06.004"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Baban B, Liu JY, Qin X, Weintraub NL and Mozaffari MS: Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153. PLoS One, 2015; 10: e0124059","DOI":"10.1371\/journal.pone.0124059"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Eppihimer MJ, Gunn J, Freeman GJ, Greenfield EA, Chernova T, Erickson J and Leonard JP: Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation, 2002; 9: 133-145","DOI":"10.1080\/713774061"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Buttic\u00e8 G, Miller J, Wang L and Smith BD: Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Circ Res, 2006; 98: 472-479","DOI":"10.1161\/01.RES.0000204725.46332.97"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Savarese G, Vedin O, D\u2019Amario D, Uijl A, Dahlstr\u00f6m U, Rosano G, Lam CSP and Lund LH: Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure. JACC Heart Fail, 2019; 7: 306-317","DOI":"10.1016\/j.jchf.2018.11.019"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Lamblin N, Meurice T, Tricot O, de Groote P, Lemesle G and Bauters C: First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis. J Card Fail, 2018; 24: 815-822","DOI":"10.1016\/j.cardfail.2018.09.013"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/4\/31_64183\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T04:46:08Z","timestamp":1712378768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/4\/31_64183\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64183","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"article-number":"64183"}}